Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
bivirkning af amoxicillin + clavulanatkalium |
Causative agent |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
allergi over for amoxicillin og clavulanatkalium |
Causative agent |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
amoxicillin + clavulanatkalium 125 mg/31 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
amoxicillin + clavulanatkalium 400 mg/57 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
co-amoxiclav 250 mg + 125 mg sukkerfri dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
co-amoxiclav 250 mg/62 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
co-amoxiclav 200 mg/28,5 mg tyggetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
co-amoxiclav 250 mg/62,5 mg tyggetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
amoxicillin 400 mg + clavulanatkalium 57 mg tyggetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
amoxicillin + clavulanatkalium 200 mg/28,5 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
co-amoxiclav 400 mg/57 mg/5 ml oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
amoxicillin med clavulanatkalium til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
amoxicillin med clavulanatkalium til parenteral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
CWD: 600mg/5ml?? amoxicillin 600 mg + clavulanatkalium 600 mg/42,9 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|
amoxicillin med clavulanatkalium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Some |
|